-
Check out my colleague
@ZafZafari’s new cost-effectiveness analysis of restrict housing vouchers to help guide housing policy!#HEOR#CEA@umsop@UMBaltimorehttps://twitter.com/zafzafari/status/1225240988387610624 … -
Are you highly skilled in quantitative sciences and experienced with programming languages? Take a look at this position working with our modeling team.
#HEOR https://bit.ly/398ndIi pic.twitter.com/zecV9bvyxa
-
This open access
systematic literature review from authors @ESHPM_EUR identified 37 unique research issues that were raised as challenges to integrating patient preferences in health technology assessment. http://ow.ly/QDx150yeDRN#HEOR#HTA#FDA#systematicreview pic.twitter.com/NElR9ZrDOx
-
Clinerion and Datametrix announced a new partnership in which the organizations will generate
#RWE insights using#RWD from Clinerion’s hospital network.#HEOR | http://ow.ly/yghH50ydsRy pic.twitter.com/DtsId9x7TL
-
"Drug Quality: FDA officials discuss perceptions" https://okt.to/0wjCRf via
@RAPSorg#HEOR#MarketAccess -
New at CADTH: updated review process, economic methods, and submission requirements >> https://okt.to/wiYLCN
#HEOR#MarketAccesspic.twitter.com/rqASETpSRq
-
Find more details about Prime Global’s new Market Access consultancy on our LinkedIn page: https://linkedin.com/showcase/primeaccessconsultancy/ … Or read more in our press release: https://primeglobalpeople.com/2020/02/04/prime-global-launch-new-market-access-consultancy-prime-access/ …
#MarketAccess#HEOR#Payer#Pharma#MedCommspic.twitter.com/vBoGDulMYZ
-
"Failed pivotal study? You can still have breakthrough therapy status — FDA signals to Resverlogix" https://okt.to/XlytLO via
@endpts#HEOR#MarketAccess -
The Medical Affairs Professional Society announced its lineup of keynote speakers for its upcoming meeting set to kick off March 8 in Miami, Florida.
#HEOR | http://ow.ly/xB0m50ydq5U pic.twitter.com/ArWDA2dGTD
-
A new FirstWord report shifts the spotlight to pricing and reimbursement for innovative drugs in major non-U.S. markets.
#HEOR | http://ow.ly/VymO50ydp6y pic.twitter.com/gKRiqaDDHu
-
A slate of Democratic legislators have invited
#insulin affordability activists as their guests to tonight’s State of the Union address, STAT reports. More details inside.#HEOR#SOTU
| http://ow.ly/6oZf50ydsh7 pic.twitter.com/acxzIHXuxd
-
A recent article published in the Journal of Medical Economics looks at the progress of Japan’s
#HTA program, which was institutionalized in April last year.#HEOR | http://ow.ly/CEbc50ycjRV pic.twitter.com/nyivDme0Xr
-
"The 10 most-anticipated drug launches of 2020" https://okt.to/iDlNVL via
@FiercePharma#HEOR#MarketAccess -
High-cost combinations >> https://okt.to/pAXWKN Will the scale of high-cost combinations coming to market force a significant change in pricing and reimbursement policies?
#MarketAccess#HEOR pic.twitter.com/JbBAD1eLG4
-
Please check out a recent paper from
@brownianmodeler in Statistics in Medicine https://onlinelibrary.wiley.com/doi/pdf/10.1002/sim.8494 … which introduces a stochastic differential equation#SDE method for modeling cohort process in decision modeling and cost-effectiveness analysis#HEOR#healthecon. In sum:Prikaži ovu nit -
Copyright Clearance Center and
@evidencepartner are joining forces to offer integrated document delivery through CCC’s cloud-based RightFind solution within Evidence Partners’ DistillerSR platform. More details inside!#HEOR | http://ow.ly/jFjH50ycetZ pic.twitter.com/8oyRzbtjUU
-
Denmark is shifting to a new evaluation system for hospital drugs based on the quality-adjusted life year, according to a Pink Sheet report.
#HEOR#QALY | http://ow.ly/I4J850ycctq pic.twitter.com/OcLAVLuN30
-
Why join us? We pride ourselves on a culture of family and opportunity. Learn more.
#HEOR https://bit.ly/31jjO6S pic.twitter.com/COmgMBjVfz
-
We've added 17,800 abstracts on
#HEOR to our database in 2019 http://ow.ly/77RK30qdOCq -
Go and check "I'm never stop" is very emotional and amazing! https://youtu.be/2kS1daCCIGM
#music#housemusic#heor#electronicmusicpic.twitter.com/eqwn2a15wQ
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.